Starting fresh with a new portfolio can be one of the most exciting—and intimidating—moments in your investing journey.

Aldeyra's Reproxalap progresses towards FDA approval, with a potential $100M AbbVie deal. There’s still upside potential, ...

Hospitals nationwide are grappling with high patient volumes, staffing shortages and inefficient capacity management — all while being asked to deliver timely, high-quality care. During a recent ...

Researchers have long been interested in how humans and animals make decisions by focusing on trial-and-error behavior ...